The TREM2 antibody: A new player in atherosclerosis
A new study has investigated the mechanisms by which the receptor TREM2 affects atherosclerosis and a possible therapeutic approach using an agonistic TREM2 antibody.
Mar 12, 2024
0
31
A new study has investigated the mechanisms by which the receptor TREM2 affects atherosclerosis and a possible therapeutic approach using an agonistic TREM2 antibody.
Mar 12, 2024
0
31
A University of Kansas study of rare gene mutations that cause hereditary Alzheimer's disease shows these mutations disrupt the production of a small sticky protein called amyloid.
Feb 29, 2024
0
67
A simple blood test to diagnose Alzheimer's disease soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.
Feb 22, 2024
0
68
According to the Alzheimer's Association, almost two-thirds of Americans with Alzheimer's dementia are women. While some of this discrepancy can be attributed to women living longer than men on average, researchers believe ...
Feb 20, 2024
0
88
On Jan. 31, aducanumab, a pricey drug approved for treatment of early-stage Alzheimer's disease, was withdrawn from the market. And in early March, the Food and Drug Administration delayed its decision regarding whether to ...
Mar 14, 2024
0
0
Monitoring daily activity patterns using a wrist-worn device may detect early warning signs of Alzheimer's disease, according to a recent study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Mar 11, 2024
0
0
Early stages of neurodegenerative disorders are characterized by the accumulation of proteins in discrete populations of brain cells and the degeneration of these cells. For most diseases, this selective vulnerability pattern ...
Mar 11, 2024
0
2
University of Virginia School of Medicine scientists have found important answers about strokes, heart attacks, and cardiovascular diseases by probing the biological glue our bodies create to protect us from those deadly ...
Mar 11, 2024
0
0
Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug's ...
Mar 8, 2024
0
0
New research suggests there is a link between abnormal blood levels of amyloid—a protein associated with Alzheimer's disease—and subtle changes in brain microstructures on a type of MRI, findings that could lead to a ...
Mar 6, 2024
0
45